Example: Heart Attack

Clinical Trials on Graves Ophthalmopathy

Total 86 results

    • NCT03922321
      Active, not recruiting
      Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy ( GO )
      Conditions: Graves' Ophthalmopathy
    • NCT02290704
      Unknown status
      Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People
      Conditions: Graves' Ophthalmopathy
    • NCT03122847
      Recruiting
      Glucocorticoids and Bone in Graves' Ophthalmopathy
      Conditions: Graves Ophthalmopathy
    • NCT03938545
      Recruiting
      ASCEND GO-2: Study of RVT-1401 for the Treatment of Patients With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )
      Conditions: Graves' Ophthalmopathy (GO)
    • NCT03324022
      Unknown status
      Observing the Relationship of Fibroblast Growth Factor and Fibroblast in Thyroid Eye Disease
      Conditions: Graves Ophthalmopathy
    • NCT04488406
      Completed
      Genetics and Epigenetics of Graves' Orbitopathy
      Conditions: Graves Ophthalmopathy
    • NCT04598815
      Not yet recruiting
      Sirolimus for Graves' Orbitopathy (GO)
      Conditions: Graves Ophthalmopathy
    • NCT01999790
      Unknown status
      Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's Orbitopathy
      Conditions: Graves Ophthalmopathy
    • NCT03278964
      Completed
      Analysis Between the Results of Two Surgical Techniques of Orbital Decompression in Patients With Graves Orbitopathy
      Conditions: Graves Ophthalmopathy
    • NCT03195296
      Completed
      T and B Cells in Graves' Orbitopathy
      Conditions: Graves Ophthalmopathy
    • NCT02339142
      Unknown status
      Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
      Conditions: Graves Ophthalmopathy
    • NCT02059655
      Completed
      Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)
      Conditions: Graves' Ophthalmopathy
    • NCT01114503
      Terminated
      A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
      Conditions: Graves Ophthalmopathy
    • NCT01969019
      Unknown status
      A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy
      Conditions: Graves' Ophthalmopathy
    • NCT00430547
      Completed
      Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
      Conditions: Graves' Ophthalmopathy
    • NCT00595335
      Completed
      Trial of Rituximab for Graves' Ophthalmopathy
      Conditions: Thyroid-associated Ophthalmopathy
    • NCT02535975
      Unknown status
      The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy
      Conditions: Mild Graves' Ophthalmopathy
    • NCT03708627
      Recruiting
      Bimatoprost as a Treatment for Graves' Orbitopathy
      Conditions: Graves Ophthalmopathy
    • NCT03066076
      Unknown status
      Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy
      Conditions: Graves Disease; Graves Ophthalmopathy; Graves' Ophthalmopathy Worsened
    • NCT01297699
      Completed
      Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
      Conditions: Thyroid Associated Ophthalmopathies; Graves´ Ophthalmopathy; Thyroid Eye Disease
    • NCT01056419
      Unknown status
      The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy
      Conditions: Graves' Ophthalmopathy
    • NCT03103607
      Completed
      Disappearance of Graves' Orbitopathy
      Conditions: Thyroid Eye Disease
    • NCT00348413
      Completed
      Thyroid Treatment Trial
      Conditions: Graves Ophthalmopathy
    • NCT00665795
      Completed
      Morphometric Analysis of Orbital Structures in Graves´ Orbitopathy
      Conditions: Dysthyroid Orbitopathy
    • NCT01809444
      Unknown status
      Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy
      Conditions: Thyroid Associated Opthalmopathies
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations